Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study (Q35124116)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study
scientific article

    Statements

    Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit